Strategic Pharma Insights: Japan’s Movers & Shakers 

Japan’s pharmaceutical market is evolving rapidly, driven by innovation, investment, and next-generation therapies. In this exclusive webinar, the AdisInsight team presents Strategic Pharma Insights: Asia Focus, Part II: Japan’s Movers & Shakers, a data-driven analysis of the key companies, emerging innovators, and strategic transactions shaping Japan’s pharma sector in 2026. Drawing on curated pipeline intelligence, the session delivers actionable insights into what’s happening and what’s next, in one of the world’s most influential life sciences markets.

  Key topics include:

• Market trends shaping Japan's pharma sector
• Leading pharma and emerging biotech companies
• Oncology, rare disease, cell & gene therapy, and CNS innovation
• Licensing, partnerships, and M&A activity
• AI-driven drug discovery and innovation trends
• Strategic opportunities in Japan's evolving market

Why Attend?

• Understand the key trends shaping Japan's pharmaceutical market in 2026
• Identify leading pharma companies, emerging biotechs, and strategic innovators
• Explore major M&A, licensing, and partnership activity driving market growth
• Gain insights into investment opportunities across high-growth therapeutic areas

Who Should Attend

• BD & Licensing professionals with Japan responsibilities
• Regulatory Affairs and Market Access teams
• Corporate Planning and Pipeline Strategy leads at pharma/biotech companies
• Competitive Intelligence and Market Research analysts
• CROs, Consultants, and advisors
• Academics and research institutions engaged in drug development or pharma-related fields